Diagnostic Imaging Europe
April 2005
Special SECTION: 3T MR
DEPARTMENTS
From The Editor
Rinckside
News
Report: Digital Department
History validates PACS' contribution to radiology
Paula Gould
Report: Historical Perspective
Diagnostic imaging makes huge technological progress
Uwe Busch, Ph.D., Arpan K. Banerjee, FRCR, and Adrian Thomas, FRCR
Report: Staff Histories
It's 1985, and a European news magazine is born
Diagnostic Imaging Editors
The Big Picture
Changes prove that some things never change
Robert Lavayssière, M.D.
FDA Grants Fast Track Designation to Emerging Agent for Brain PET Imaging
June 11th 2025Currently being evaluated in a phase 2b clinical trial, the 18F-RAD101 PET imaging agent garnered the FDA’s fast track designation for distinguishing between recurrent disease and treatment impact for brain metastases derived from solid tumors.
New PSMA PET Prep Product Now Available in the U.S.
June 11th 2025Offering an extended shelf life, the FDA-approved Gozellix, a preparation kit for gallium-68 (68Ga) gozetotide injection, is indicated for use in PSMA PET imaging of prostate cancer patients with suspected recurrence or metastasis.